The Central Drugs Standard Control Organisation (CDSCO) has approved the extension of Bharat Biotech's Covid-19 vaccine Covaxin's shelf life up to 12 months from the date of manufacture, the vaccine-maker said.

"This approval of shelf life extension is based on the availability of additional stability data, which was submitted to CDSCO. With the shelf life extension, hospitals can now utilise the stock to avoid vaccine wastage, a press release said.